Application 074969
- Type
- ANDA
- Sponsor
- TEVA PARENTERAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACYCLOVIR SODIUM | ACYCLOVIR SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 002 | ACYCLOVIR SODIUM | ACYCLOVIR SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074969-001 | ACYCLOVIR SODIUM | ACYCLOVIR SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1997-08-26 | ||
| A074969-002 | ACYCLOVIR SODIUM | ACYCLOVIR SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1997-08-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074969-001 | ACYCLOVIR SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1997-08-26 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A074969-002 | ACYCLOVIR SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1997-08-26 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir Sodium | ACYCLOVIR SODIUM | ProPharma Distribution | 23a7cf9e-f21b-06c2-e063-6394a90aa623 | 2025-07-18 | Warnings, Adverse reactions | Acyclovir Sodium ACYCLOVIR SODIUM |
| Acyclovir Sodium | ACYCLOVIR SODIUM | Eugia US LLC | ae921e4e-b8ae-4a45-acc1-32e5e719812b | 2023-07-05 | Warnings, Adverse reactions | Acyclovir Sodium ACYCLOVIR SODIUM |
| Acyclovir Sodium | ACYCLOVIR SODIUM | AuroMedics Pharma LLC | d3ab226c-677d-4cb7-85cb-1c2e5012f40d | 2017-09-18 | Warnings, Adverse reactions | Acyclovir Sodium ACYCLOVIR SODIUM |